Literature DB >> 22329572

Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Shigella flexneri subserotype 1c isolates from China.

S Qiu1, X Xu, Y Wang, G Yang, Z Wang, H Wang, L Zhang, N Liu, C Chen, W Liu, J Li, W Su, L Jia, L Wang, H Jin, P Keim, Z Yuan, L Huang, H Song.   

Abstract

We report here on the first identification of Shigella flexneri subserotype 1c in China. We also report the emergence of resistance to ciprofloxacin and third-generation cephalosporins in this subserotype 1c for the first time. Isolates of seven strains circulating in China yielded three new sequence types and seven pulsed-field gel electrophoresis patterns, thus demonstrating the existence of high genetic diversity within the isolates. Overall, the seven isolates showed reduced susceptibility to ciprofloxacin; one isolate was ciprofloxacin resistant, whilst another developed resistance to ciprofloxacin, norfloxacin, cefotaxime and ceftriaxone.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22329572     DOI: 10.1111/j.1469-0691.2012.03768.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Antimicrobial Resistance of Shigella flexneri in Pakistani Pediatric Population Reveals an Increased Trend of Third-Generation Cephalosporin Resistance.

Authors:  Iqbal Nisa; Mohammad Haroon; Arnold Driessen; Jeroen Nijland; Hazir Rahman; Nusrat Yasin; Mubashir Hussain; Taj Ali Khan; Amjad Ali; Saeed Ahmad Khan; Muhammad Qasim
Journal:  Curr Microbiol       Date:  2022-02-27       Impact factor: 2.188

2.  Serotype distribution and characteristics of antimicrobial resistance in Shigella isolated from Henan province, China, 2001-2008.

Authors:  H Yang; W Sun; G Duan; J Zhu; W Zhang; Y Xi; Q Fan
Journal:  Epidemiol Infect       Date:  2012-11-14       Impact factor: 4.434

3.  Gallic acid conjugated with gold nanoparticles: antibacterial activity and mechanism of action on foodborne pathogens.

Authors:  Narintorn Rattanata; Sompong Klaynongsruang; Chanvit Leelayuwat; Temduang Limpaiboon; Aroonlug Lulitanond; Patcharee Boonsiri; Sirinart Chio-Srichan; Siriwat Soontaranon; Supagorn Rugmai; Jureerut Daduang
Journal:  Int J Nanomedicine       Date:  2016-07-27

Review 4.  Single Domain Antibodies as New Biomarker Detectors.

Authors:  Chiuan Herng Leow; Katja Fischer; Chiuan Yee Leow; Qin Cheng; Candy Chuah; James McCarthy
Journal:  Diagnostics (Basel)       Date:  2017-10-17

5.  Out of Asia: the independent rise and global spread of fluoroquinolone-resistant Shigella.

Authors:  Hao Chung The; Stephen Baker
Journal:  Microb Genom       Date:  2018-03-29

6.  Clonal serotype 1c multidrug-resistant Shigella flexneri detected in multiple institutions by sentinel-site sequencing.

Authors:  Karrie K K Ko; Joash Jun Keat Chu; Kar Mun Lim; Hatairat Yingtaweesittikul; Wenjie Huang; Shireen Yan Ling Tan; Kenneth Choon Meng Goh; Si Huei Tan; Tong Yong Ng; Matthias Maiwald; Jonathan Wei Zhong Chia; Delphine Yanhong Cao; Yen Ee Tan; James Heng Chiak Sim; Tse Hsien Koh; Niranjan Nagarajan; Chayaporn Suphavilai
Journal:  Front Med (Lausanne)       Date:  2022-08-01

7.  Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri.

Authors:  Anthony A Emanuele; Nancy E Adams; Yi-Chen Chen; Anthony T Maurelli; George A Garcia
Journal:  J Antibiot (Tokyo)       Date:  2014-02-19       Impact factor: 2.649

8.  Bacteriophages are the major drivers of Shigella flexneri serotype 1c genome plasticity: a complete genome analysis.

Authors:  Pawan Parajuli; Marcin Adamski; Naresh K Verma
Journal:  BMC Genomics       Date:  2017-09-12       Impact factor: 3.969

9.  Newly Emerged Serotype 1c of Shigella flexneri: Multiple Origins and Changing Drug Resistance Landscape.

Authors:  Pawan Parajuli; Bui Quang Minh; Naresh K Verma
Journal:  Genes (Basel)       Date:  2020-09-03       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.